[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:urea-cycle-metabolism-disorder":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":53,"states":54},"Urea Cycle Metabolism Disorder",7,6,[8,16,22,28,34,40,46],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07667387","A Phase I\u002FII Open-label Safety and Efficacy Study of LNP.UCD.ABE in Patients With Urea Cycle Disorders.",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:25.327036Z","2026-07-05T03:45:20.368576Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07701694","Functional Evaluation in Patients With Urea Cycle Disorders (UCD) During a Driving Task",[],"2026-08-26T02:17:51.502023Z","2026-07-19T19:36:05.083291Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT03409003","Orphan Europe Carbaglu® Surveillance Protocol",[],"2026-08-26T02:17:35.666428Z","2026-05-13T02:55:06.123827Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT04908319","Hepatic Histopathology in Urea Cycle Disorders",[],"2026-08-26T02:15:10.362237Z","2026-05-13T02:55:06.274828Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT04602325","Systemic Biomarkers of Brain Injury From Hyperammonemia",[],"2026-08-26T02:18:57.189473Z","2026-05-13T02:55:06.255953Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":44,"content_modified":45},"NCT00237315","Longitudinal Study of Urea Cycle Disorders",[],"2026-08-03T02:27:16.454962Z","2026-05-13T02:55:06.033990Z",{"nct_id":47,"title":48,"phases":49,"status":50,"updated_at":51,"content_modified":52},"NCT02935283","Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders",[],"UNKNOWN","2026-08-03T03:20:51.997416Z","2026-05-13T02:55:06.103614Z",[],[55],{"state":56,"count":57,"slug":58},"District of Columbia",5,"district-of-columbia"]